Patents Examined by Blessing M. Fubara
  • Patent number: 11364190
    Abstract: A self-foaming cleansing composition are provided. The self-foaming composition includes a) from about 0.5% to about 10% wt. % of one or more volatile silicone oils; b) from about 0.5% to about 25% wt. % of one or more surfactants stable at low pH; c) from about at least 1.2% of one or more polymers with suspending properties; d) from about 0.5% to about 5% wt % of one or more thickeners; e) from about 0.5% to about 15% wt. % of one organic acid as cosmetic active ingredient; the self-foaming cleansing composition having a pH in between about 3.4 and 5; the self-foaming cleansing composition starting to foam immediately after application of the compositions onto the skin; wherein the foaming cleansing composition is free of perfluoro compound; and wherein the weight percentages are based on the total weight of the self-foaming cleansing composition.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: June 21, 2022
    Assignee: L'OREAL
    Inventors: Nicholas David Stebbins, Susan Halpern Chirch, Ryuji Hara
  • Patent number: 11363814
    Abstract: According to one embodiment, a method of managing messages in a trading network is provided. A set of user relationships between a first user and one or more second users authorized to act on behalf of the first user is stored. A trading message regarding a trading order submitted on behalf of the first user is received from a trading system. The trading message is communicated to the first user. Each of the second users is identifying from the set of user relationships. For each of the identified second users, a carrier message is generated that includes the trading message and routing information associated with that second user. For each of the identified second users, the respective carrier message is communicated toward a user application associated with that second user based at least on the routing information included in the respective carrier message.
    Type: Grant
    Filed: July 16, 2020
    Date of Patent: June 21, 2022
    Inventor: Jan Willem Toebes
  • Patent number: 11351108
    Abstract: The present invention relates to a finger-moldable composition capable of forming a free-standing coating and suitable for application to, for example, human lips. The composition includes a thermoplastic block copolymer that includes styrenated blocks. It further includes a sufficient amount of cosmetic oil to allow a human user to mold the composition readily with the user's fingers and form a free-standing film.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: June 7, 2022
    Assignee: L'OREAL
    Inventors: Andrea E. Schott, Alexandra Farran, Anne-Laure Bernard, Erin McMullin
  • Patent number: 11337899
    Abstract: Provided herein is a cosmetic composition comprising gellant technology combined with at least two different gelling agents; neutralizing agent; colorant; and water.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: May 24, 2022
    Assignee: Noxell Corporation
    Inventors: Ken Nguyen, Johanne Richard
  • Patent number: 11331336
    Abstract: Described herein are pet food compositions comprising: a beta glucan; and a pentacyclic triterpene; wherein the weight ratio of the beta glucan to the pentacyclic triterpene, is about 1:1. Methods of making and using these compositions are also described.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: May 17, 2022
    Assignee: Hills Pet Nutrition, Inc.
    Inventors: Matthew Jackson, Dennis Jewell, Kiran Panickar
  • Patent number: 11330820
    Abstract: Pesticidal mixtures including a pesticidally active compound I selected from: a) compound a) of formula (I). b) compound b) of formula (Ia), c) mixtures comprising compounds a) and b), and at least one further pesticidal active ingredient are disclosed. Methods and use of these mixtures for combating and controlling insects, acarids or nematodes in and on plants, and for protecting such plants being infested with pests are disclosed.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: May 17, 2022
    Assignee: BASF SE
    Inventors: Robert Reinhard, Tatjana Sikuljak, Pascal Bindschaedler, Karsten Koerber, Juergen Langewald
  • Patent number: 11331271
    Abstract: Methods for buccally, sublingually, or intranasally administering a prodrug of propofol to a subject in need of treatment thereof in an amount sufficient to deliver a therapeutically effective amount of propofol to the subject are disclosed.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: May 17, 2022
    Assignee: The Johns Hopkins University
    Inventors: Barbara Slusher, Rana Rais, James Vornov
  • Patent number: 11318150
    Abstract: A vitamin supplement composition that includes a complex with enhanced bioavailability having a vitamin B complex, wherein the vitamin B complex includes: (a) a first vitamin, wherein the first vitamin comprises a form of vitamin B6; (b) a second vitamin, wherein the second vitamin comprises a form of vitamin B9; (c) a third vitamin, wherein the third vitamin comprises a form of vitamin B12; and (d) wherein the first vitamin, the second vitamin, and the third vitamin cooperate synergistically to enhance bioavailability of the same. The present invention further includes a method of administering a vitamin supplement composition to an individual having, for example, MTHFR deficiency.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: May 3, 2022
    Inventor: Michelle Ann Toothman
  • Patent number: 11304909
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: April 19, 2022
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Patent number: 11304908
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: April 19, 2022
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Patent number: 11298322
    Abstract: The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: April 12, 2022
    Inventors: William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
  • Patent number: 11298302
    Abstract: The present invention provides a water-in-oil type emulsion cosmetic which has a fresh and smooth feeling to the touch; forms a uniform coating film once applied; can make skin unevenness such as pores look less prominent while covering discolorations such as age spots and freckles; and does not give an impression of thick application. The water-in-oil emulsion cosmetic is characterized by including (A) 0.1-10% by mass of a pigment-grade titanium dioxide and (B) 0.01-2% by mass of sodium acrylate grafted starch. It is preferred that this cosmetic further includes (C) spherical particles and/or (D) a silicone elastomer.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: April 12, 2022
    Assignee: SHISEIDO COMPANY, LTD.
    Inventors: Shoji Tajima, Tomoko Ikeda
  • Patent number: 11291483
    Abstract: A composite implant comprising a bioabsorbable matrix material, an outer sheath of a textile comprising filaments; and a plurality of flexible reinforcing rods held together by the outer sheath; each of the flexible reinforcing rods have a plurality of filaments, and the filaments of the textile and the flexible reinforcing rods include a degradable or resorbable glass. Preferably, the filaments are present in the composite implant in an amount of 20 volume percent to 95 volume percent, based on the total volume of the composite implant.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: April 5, 2022
    Assignee: 206 ORTHO, Inc.
    Inventors: Jeffrey A. D'Agostino, Andrew J. Carter, Arthur Watterson, Joseph P. Lane
  • Patent number: 11272707
    Abstract: An object of the present invention is to provide a composition which is excellent in plant disease control effect without causing significant injury to the plants. A liquid composition comprising mefentrifluconazole, a Nonionic Surfactant (NIS), and water, wherein the weight ratio of mefentrifluconazole to the NIS is in the range of 1:0.1 to 1:10.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: March 15, 2022
    Assignee: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Atsushi Watanabe, Yoshinao Sada
  • Patent number: 11266628
    Abstract: The present invention relates to a disintegrant free pharmaceutical composition comprising apremilast or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients. Particularly the present invention relates to disintegrant free immediate release dosage form comprising apremilast or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients. It further relates to process of preparing such composition and its use in psoriatic arthritis and psoriasis.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: March 8, 2022
    Assignee: UNICHEM LABORATORIES LTD
    Inventors: Dhananjay Sathe, Srikant Pimple, Pradeep Kumar Gupta, Vishal Jadhav
  • Patent number: 11253595
    Abstract: This disclosure relates to treatments for reducing the side effects associated with treatment of a medication or drug, such as a chemotherapy medication, being experienced by a patient. This may be accomplished by administering to a patient taking the medication, a buffered aqueous liquid having a pH of about 10 to about 11.5, wherein the buffered aqueous liquid comprises sodium bicarbonate, sodium carbonate, and trisodium phosphate.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: February 22, 2022
    Inventor: Al Siamon
  • Patent number: 11246932
    Abstract: Compositions and methods for the treatment of vasospasm are provided comprising applying an amount of a semi-solid vasoactive prostaglandin composition to the affected tissue. Also provided are methods of improving microcirculation in a replanted body part.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: February 15, 2022
    Assignee: NEXMED HOLDINGS, INC.
    Inventors: Tian Wen, Liu Liu, Mingqi Lu, Jieshan Bai, Y. Joseph Mo
  • Patent number: 11241517
    Abstract: Provided are a hydrogel composition with high viscoelasticity and a bioink composition including the hydrogel composition. The hydrogel composition according to an embodiment is composed of natural biocompatible substances and thus is not toxic, but has high viscosity, resulting in high mechanical stability or long persistence. Thus, the hydrogel composition may be usefully utilized as a bioink composition for bioprinting, a support in tissue engineering, or a soft tissue filler.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: February 8, 2022
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Sang Heon Kim, Joo Young Lee, Seung Ja Oh
  • Patent number: 11241383
    Abstract: Alprazolam formulated as an inhaled condensation aerosol and method for treating epilepsy and/or seizures.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: February 8, 2022
    Assignee: ALEXZA PHARMACEUTICALS, INC.
    Inventors: James Cassella, Lily Gong, Edwin S. Kamemoto
  • Patent number: 11241388
    Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: February 8, 2022
    Assignee: JDS Therapeutics, LLC
    Inventor: James R. Komorowski